Adalimumab
Adalimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNFα). Adalimumab has been used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
Supplier | BOC Sciences |
---|---|
Product # | 331731-18-1 |
Pricing | Inquire |
Cas | 331731-18-1 |
Molecular Weight | 144 kDa |
Molecular Formula | C6428H9912N1694O1987S46 |